Specimen Validity Testing Market Trends and Future Outlook

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Specimen Validity Testing Market Expected To Scale Between 2026 And 2030?

The size of the specimen validity testing market has experienced substantial growth in recent years. It is anticipated to increase from $4.03 billion in 2025 to $4.4 billion in 2026, with a compound annual growth rate (CAGR) of 9.3%. This historical growth can be attributed to factors such as growth in workplace drug testing, regulatory mandates for urine testing, a rise in substance abuse cases, demand for forensic testing, and the expansion of clinical laboratories.

The specimen validity testing market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $5.95 billion, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth throughout the forecast period stems from factors such as the greater acceptance of oral fluid testing, enhancements in assay sensitivity through technology, a rise in probation and legal testing requirements, the broadened availability of point-of-care solutions, and deeper penetration into developing markets. Key trends during this timeframe encompass the development of more comprehensive adulterant detection panels, the automation of validity testing processes, better integration with laboratory information systems, the introduction of rapid testing kits, and the expansion of drug screening programs in workplaces.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

Which Factors Are Influencing The Growth Of The Specimen Validity Testing Market?

The specimen validity testing market is anticipated to expand due to the rising incidence of drug abuse, which involves the excessive or inappropriate use of legal or illegal substances for non-medical purposes. This increase is driven by multiple factors, including the opioid crisis, growing mental health issues, limited access to treatment and support services, and social influences. Specimen validity testing (SVT) methods are used to detect adulteration and ensure sample integrity by analyzing parameters such as pH, specific gravity, creatinine levels, and temperature. For example, according to the Office for National Statistics, a UK government body, in October 2024, there were 5,448 drug poisoning-related deaths recorded in England and Wales in 2023, reflecting an 11.0% increase from 4,907 deaths in 2022. As a result, the rise in drug abuse is expected to drive growth in the specimen validity testing market.

How Is The Specimen Validity Testing Market Segmented Across Different Segment Categories?

The specimen validity testing market covered in this report is segmented –

1) By Product And Service: Products, Service

2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing

3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users

Subsegments:

1) By Products: Reagents And Assay Kits, Controls And Calibrators, Specimen Collection Devices, Analyzers And Instruments

2) By Service: Laboratory Testing Services, Point-Of-Care Testing Services

Which Organizations Play A Role In The Specimen Validity Testing Market Landscape?

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd

Get The Full Specimen Validity Testing Market Report:

https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Which Region Is The Leading Market For The Specimen Validity Testing Market?

North America was the largest region in the specimen validity testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Specimen Validity Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Browse Through More Reports Similar to the Global Specimen Validity Testing Market 2026, By The Business Research Company

Laboratory Proficiency Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/laboratory-proficiency-testing-global-market-report

Dna Testing Market Report

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Virology Specimen Collection Market Report

https://www.thebusinessresearchcompany.com/report/virology-specimen-collection-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795